Day: January 21, 2021

Churchill Downs Incorporated to Launch TwinSpires Sportsbook and iGaming Platform in Michigan

LOUISVILLE, Ky., Jan. 21, 2021 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “Company”) (Nasdaq: CHDN) announced today the launch of its TwinSpires Sportsbook and iGaming platform in Michigan on Friday, January 22, 2021 at 12:00 p.m. EST on iOS and android as well as desktop. The online debut builds upon CDI’s established presence in Michigan following the September 2020 opening of a retail sportsbook at Island Resort & Casino in Harris, Michigan in partnership with Hannahville Indian Community.“We couldn’t be more excited to officially launch our state-of-the-art TwinSpires Sportsbook and iGaming platform in Michigan,” said Bill Mudd, president and COO of CDI. “Michigan sports and gaming enthusiasts will now be able to access TwinSpires’ market-leading promotions and in-game sports betting as well as best-in-class...

Continue reading

Orca Energy Group Inc. Announces Final Results of Substantial Issuer Bid

TORTOLA, British Virgin Islands, Jan. 21, 2021 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today is announcing the final results of its substantial issuer bid commenced on December 16, 2020, pursuant to which the Company offered to purchase for cancellation a number of its Class B Subordinate Voting Shares (“Class B Shares“) for an aggregate purchase price not to exceed CDN$40 million at a purchase price of not less than CDN$6.50 and not more than CDN$7.50 per Class B Share (the “Offer“). The Offer expired at 5:00 p.m. (Toronto time) on Wednesday January 20, 2021. All dollar amounts are in Canadian dollars.In accordance with the terms and conditions of the Offer, and based on the final information...

Continue reading

Immutep Quarterly Activities Report

HighlightsEncouraging efti data reported from phase IIb AIPAC and phase II TACTI-002 clinical trialsTACTI-002 study expanded in lung cancerNew phase II trial in head and neck cancer announcedEOC Pharma starts new phase II study in metastatic breast cancerRobust operational and financial position, with $54.9 million in cash as at 31 December 2020, providing cash runway beyond the end of calendar year 2022Sydney, AUSTRALIA, Jan. 22, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, provides an update on the ongoing development of its product candidates, eftilagimod alpha (“efti” or “IMP321”) and IMP761, and the activities of its partners.“Immutep has entered calendar year 2021 in...

Continue reading

Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

Sydney, AUSTRALIA, Jan. 22, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, advises that one of its licensing partners, GSK, has discontinued its Phase II clinical trial evaluating an anti-LAG3 cell depleting monoclonal antibody, GSK2831781 (derived from Immutep’s IMP731 antibody), in patients with active  ulcerative colitis.The trial was stopped by GSK based on the assessment of clinical data as part of a planned interim analysis  conducted in consultation with the trial’s Data Review Committee. GSK is conducting further reporting, assessment and analyses of the efficacy and safety data and evaluating the biology to determine next steps for the GSK2831781 development program.Immutep’s...

Continue reading

HV Bancorp, Inc. Announces New Vice-Chairman and Committee Chairs

Doylestown, Pa., Jan. 21, 2021 (GLOBE NEWSWIRE) — HV Bancorp, Inc., (NASDAQ: HVBC) announced the appointment of Robert J. Marino to the position of Vice-Chairman of the Board of Directors of Huntingdon Valley Bank and HV Bancorp, Inc. Mr. Marino replaces Scott W. Froggatt, who had served in this position for the past several years. Mr. Froggatt will continue to serve as Director.Travis J. Thompson, Esq., Chairman, President & CEO, commented, “We are pleased to have such a talented and dedicated Board continue to guide HVB as we build our vision of a better experience bank in the Philadelphia market place. While we acknowledge and thank Mr. Froggatt for his contributions over the past several years as Vice-Chairman, we look forward to Bob Marino’s new and expanded role with HVB. With over 30 years’ experience in banking,...

Continue reading

Huckleberry East Zone Drilling Confirms Copper Mineralization at Depth

VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports assay results from the final two drill holes of the 2020 diamond drilling at its Huckleberry property.Three drill holes totaling 2,491 metres in length were completed during the 2020 third quarter. The objective of the drill program was to test the continuation of copper mineralization at depth beneath the East zone pit, which produced about 50 million tonnes of ore grading 0.55% copper between 1997 and 2007. The East zone was mined to a depth of about 200 metres. Mining to date at Huckleberry has been from two zones of mineralization, the East and Main zones, with the East zone containing the higher-grade copper mineralization.As reported on November 9, 2020, the first drill hole H20E-416 intercepted 0.35%...

Continue reading

Altus Midstream Company to Host Fourth-Quarter and Full-Year 2020 Results Conference Call Feb. 25 at 1 p.m. Central Time

HOUSTON, Jan. 21, 2021 (GLOBE NEWSWIRE) — Altus Midstream Company (Nasdaq: ALTM) (“Altus”) will host its fourth-quarter and full-year 2020 results conference call Thursday, Feb. 25, 2021, at 1 p.m. Central time. The company will issue its earnings release after close of market Wednesday, Feb. 24. The full text of the release will be available on the company’s website at www.altusmidstream.com.The conference call will be webcast from Altus’ website at www.altusmidstream.com/investors, and the webcast replay will be archived there as well. The conference call will also be available for playback by telephone for one week beginning at approximately 6 p.m. Central time Feb. 25. To access the telephone playback, dial (855) 859-2056 or (404) 537-3406 for international calls. The conference access code is 2394549.About Altus Midstream...

Continue reading

MDxHealth Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAWNEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 11:30 p.m. CETIRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares. The Company raised EUR 25.0 million (USD 30.4 million)(1) in gross proceeds by means of a private placement of 27,777,777 new shares (being approximately 30.63% of the Company’s outstanding shares) at an issue price of EUR 0.90...

Continue reading

MDxHealth Réalise avec Succès une Augmentation de Capital à Hauteur de € 25,0 Millions ($ 30,4 Millions)(1)

CETTE ANNONCE N’EST PAS DESTINÉE À ÊTRE DISTRIBUÉE, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD OU DANS TOUTE AUTRE JURIDICTION OÙ CELA SERAIT INTERDIT PAR LA LOICOMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE – INFORMATION PRIVILÉGIÉE21 janvier 2021, 23h30 HECIRVINE, CA, et HERSTAL, BELGIQUE – le 22 janvier 2021 – MDxHealth SA (Euronext Brussels: MDXH) (la “Société” ou “MDxHealth“), une société spécialisée dans le diagnostic moléculaire à un stade commercial, annonce le succès de la fixation du prix de son augmentation de capital avec l’émission de nouvelles actions ordinaires. La Société a levé € 25,0 millions (ou $ 30,4 millions)(1) de fonds bruts par le biais d’un placement privé de 27.777.777 nouvelles actions (soit environ...

Continue reading

Timbercreek Financial Declares January 2021 Dividend

TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that its board of directors (the “Board”) has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on February 15, 2021 to holders of Common Shares of record on January 29, 2021.The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees.Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent...

Continue reading

Disclaimer & Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.